HOME >> BIOLOGY >> NEWS
Results of world's first gene therapy trial for arthritis show approach safe, feasible

PITTSBURGH, June 6 Gene therapy for arthritis and other non-terminal, debilitating conditions and diseases is both feasible and safe, report researchers who conducted the world's first such test on the approach in patients with advanced rheumatoid arthritis. The results, published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS), indicate that introducing a new gene has the potential to block the destructive inflammation process that takes place within arthritic joints. At a time when setbacks have cast doubt on the future of gene therapy, the results also provide assurance that it can be performed without causing undue harm to patients.

The clinical trial, which was conducted at the University of Pittsburgh School of Medicine between 1996 and 1999, involved nine women who had genetically modified cells injected into their arthritic knuckles and marked the first time a gene was introduced into a human joint. The researchers say their results showing that successful gene transfer can target joint inflammation open the door to the development of improved gene-based therapies for both rheumatoid and the more common osteoarthritis, which together affect about 66 million people in the United States. While the Pitt study used the same vector an inactivated virus that shuttles a gene into cells as a more recent French trial for X-linked severe combined immunodeficiency (X-SCID) in which three children later developed leukemia, the researchers point out that this is the only similarity between the two trials. The studies were concerned with different genes and with different targets, and in the arthritis trial, the transduced cells were removed after one week during routine joint replacement surgery. Nonetheless, with safety a key concern, the authors report no clinical side effects up to five years after the procedure and no evidence that the vector, a replication-defective retrovirus called Maloney Murine Leukemia Viru
'"/>


6-Jun-2005


Page: 1 2 3 4

Related biology news :

1. Combating anthrax: Results of study published this month as researchers look for a better vaccine
2. NASA-funded robotic sub finds bottom of worlds deepest sinkhole
3. Genome of Clostridium botulinum reveals the background to worlds deadliest toxin
4. Journal details how global warming will affect the worlds fisheries
5. NASA mission explores worlds deepest sinkhole
6. 20 of worlds 162 grouper species threatened with extinction
7. Failure to meet United Nations sanitation target could affect millions of the worlds poorest
8. Are we killing the worlds oceans?
9. LIAI completes worlds most comprehensive analysis on influenza virus data
10. Thorium poised to meet worlds energy needs
11. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device

Post Your Comments:
(Date:5/24/2013)... for medication against Alzheimer,s disease, scientists have focused among ... beta (A-beta). After all, it is the accumulation of A-beta ... patients. Starting point for the formation of A-beta is APP. ... to unravel the function of APPL the fruit-fly version ... , Alessia Soldano (VIB/KU Leuven): "We have discovered that ...
(Date:5/23/2013)... popular fruit, can be made both better-tasting and longer-lasting ... , "Working with GM tomatoes that are different to ... compound, allows us to pinpoint exactly how to breed ... John Innes Centre. , The research could also lead ... life characteristics because even higher levels of the compounds ...
(Date:5/23/2013)... Health at Emory University, along with partners at ... $4 million grant over four years to establish ... Exposome Research Center: Understanding Lifetime Exposures). The grant ... the United States. , The HERCULES Center ... Health Sciences (NIEHS) of the National Institutes of ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2The world's favorite fruit only better-tasting and longer-lasting 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/24/2013)... 24, 2013 Bed bug cases tend to ... from the looming higher risk of becoming the pests' next ... bed bug guideline. In the guide, the company enumerated the ... avoiding them while traveling. , According to My Cleaning ... of bed bug infestation during summer: the warm weather and ...
(Date:5/24/2013)... May 24, 2013 This market ... on kinase profiling carried out in May 2013. ... the breakdown of the responses for each question, ... (2015). It also highlights some interesting differences, particularly ... Two bottom-up models were developed to estimate the ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") ... science-based research and development, sales and marketing of ... announced today that it is awarding exclusive Vestiage ... of Reluma Skin Illuminating Facial Care. Qualified applicants ... sending an email to info(at)vestiageinc(dot)com and putting RELUMA ...
(Date:5/23/2013)... Mich. Every day, their baby stopped breathing, his ... his lungs. April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good ... Gionfriddo, about her now 20-month-old son, Kaiba. "At that ... would take it and run with it." , They ...
Breaking Biology Technology:Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3
Cached News: